Introduction
The evaluation of unexpected large or potentially lifethreatening bruises requires an assessment of vascular integrity, platelet functions and plasma factors [1, 2] . Pa-gery, cholecystectomy, and breast biopsy for a benign mass. She is a housewife, mother of 2 children and there was no family history of abnormal bleeding. Also there was no history of abnormal bleeding with previous surgeries or during deliveries. Medications were omeprazole, amitriptyline, and lovastatin. She did not smoke, nor did she use alcohol or drugs. Other pertinent positive clinical symptoms were myalgia and dry mouth. On physical examination, she was afebrile with a blood pressure of 140/90 mm Hg, a pulse rate of 86/min, and a dry oral mucosa. Cardiac examination revealed normal heart sounds without a murmur or rubs. The lung auscultation was unremarkable. Abdominal examination revealed 7 ! 6 cm ecchymosis over the right anterior abdominal wall. The abdomen was soft with mild tenderness over the bruise mark. There were no palpable masses or organomegaly. The extremities had no edema or calf tenderness. No other bruise marks or joint swellings were noted.
The laboratory results were as follows: white blood count, 5.1 ! 10 3 /mm 3 ; hemoglobin, 11.6 g/dl; platelet count, 238 ! 10 3 / mm 3 . Liver and renal functions were normal. Her prothrombin time was 11.3 s with an international normalized ratio of 1.1. The antinuclear antibody titer was 1: 40 with a diffuse pattern. Antiextractable nuclear antigen, anticardiolipin, C-reactive protein, C3, C4, total complement, peripheral antineutrophil cytoplasmic antibodies, cytoplasmic antineutrophil cytoplasmic antibodies, Sjögren's syndrome antibodies (anti-SSA, anti-SSB), angiotensinconverting enzyme and rheumatoid factor were not consistent with any defined autoimmune illness. The activated partial thromboplastin time (APTT) was 53 s (normal ! 35), and computed tomography scan of the abdomen and pelvis showed a subcutaneous hematoma measuring 2.8 ! 3.1 cm beneath the site of the obvious bruise. The differential diagnosis includes deficiency or inhibitors of factors VIII, IX and XI or antiphospholipid antibody.
Her factor VIII level was ! 1% (normal 50-180%), consistent with acquired hemophilia A. The patient was started on treatment with prednisone 40 mg/day and Cytoxan 50 mg/day until the bleeding resolved. The doses of both medications were then gradually reduced. The patient underwent a workup for lymphoma/ cancer with a chest X-ray, computed tomography scan, and bone marrow biopsy, all of which were normal. After the treatment, the APTT levels normalized within a few weeks and her factor VIII activity increased from 1 to 1 21% with no additional bleeding episodes. She was followed up weekly, then monthly as bleeding symptoms decreased and factor VIII levels normalized.
Discussion
Acquired hemophilia A is a rare disease associated with severe bleeding complications. It is typically caused by a congenital deficiency of factor VIII, but an acquired form due to inhibitors to factor VIII occurs later in life [3] . The term 'acquired hemophilia' is derived from the fact that the inhibitors to factor VIII create a functional coagulation factor VIII deficiency in individuals who have no prior history of bleeding [4] . Unlike congenital hemophilia A, where hemarthrosis is a typical feature, the bleeding pattern in acquired hemophilia A is different in the sense that these patients experience hemorrhages into the skin, muscles or soft tissues, and mucous membranes, as presented in our case. Moreover, there is no known genetic inheritance pattern and thus this condition occurs equally in men and women [5, 6] . The incidence of acquired hemophilia increases with age (the median age at presentation is somewhere between 60 and 67 years) as in the case of the 60-year-old woman. An underlying pathology like autoimmune disorders, malignancy, or pregnancy is observed in 50% of cases, but since all these workups were negative, our case falls into the remaining 50% of cases that are idiopathic [4] . The timely detection of this condition is critical, since early therapy directed towards achieving hemostasis and inhibitor eradication is life-saving [3] . The diagnosis of acquired hemophilia A in a patient with no previous personal or family history of bleeding is typically based on two factors: prolonged APTT and a normal prothrombin time indicating an abnormality in the early part of the intrinsic coagulation cascade. In mixing studies, correction of APTT implies a deficiency, whereas persistence of an abnormally prolonged APTT suggests the presence of an inhibitor [7] . In our case, the patient's APTT was 53 s with factor VIII levels of ! 1% indicating acquired hemophilia A. Treatment of acquired hemophilia is aimed at controlling hemorrhage and ameliorating autoantibody formation [8] . Therapy includes immunosuppression with high-dose corticosteroids, and cyclophosphamide, or with factor VIII supplements [8] . The patient in our case was treated with prednisone 40 mg/day and Cytoxan 50 mg/day until the bleeding resolved and her factor VIII Color version available online level normalized. During the acute phase, patients with low-titer inhibitors can be treated using human factor VIII concentrates, whereas in patients with high titer it is not possible to overcome the inhibiting activity by raising the factor VIII level. Therefore, factor VIII bypassing agents, such as activated prothrombin complex concentrates or recombinant activated factor VII, are used [4] .
